INVESTOR

Novavax to Host an Analyst and Investor Meeting with Webcast

Tuesday, September 23, 2014

Senior management will conduct a series of presentations to update analysts and investors as to the company's recombinant nanoparticle vaccine technology, its RSV F-protein vaccine candidate and its influenza vaccine candidates.

Live Teleconference Information

Primary # -
877-212-6076
Secondary # -
707-287-9331
Passcode -
5159787

Get notifications for investor updates

Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.

Go to email subscription
Investor inquiries

Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at [email protected]

Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.

Graph icon